Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 174

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Unexplained Recurrent Miscarriage and Recurrent Implantation Failure: Is There a Place for Immunomodulation?

Mekinian, Arsène, Cohen, Jonathan, Alijotas‐Reig, Jaume, Carbillon, Lionel, Nicaise‐Roland, Pascale, Kayem, Gilles, Daraï, Emile, Fain, Olivier, Bornes, Marie·2016·American Journal of Reproductive Immunology

Abstract

To describe and analyze the benefit of immunomodulatory drugs for recurrent miscarriages and implantation failures. The literature research was conducted in Medline, Embase and Cochrane Library concerning recurrent miscarriages and implantation failures and steroids, progesterone, intralipids, TNF ‐α antagonists, G‐ CSF , hydroxychloroquine, intravenous immunoglobulins, endometrial scratching. Using meta‐analysis, modest benefit was found for progesterone to obtain a live birth, with odds ratio at 1.38 (95% CI : 1.07–1.77) and significant heterogeneity ( P = 0.01, I 2 = 78%). In early ≥3 miscarriages, patients treated by TNF ‐α antagonists (adalimumab or etanercept; n = 17) combined with low‐dose aspirin, heparin and intravenous immunoglobulins have a live births of 71% (12/17), vs 19% with aspirin+heparin (4/21) ( P = 0.0026). Sixty‐eight patients with unexplained recurrent miscarriage were randomized to receive either G‐ CSF (filgastrim, Neupogen, 1 μ/kg/day SC , n = 35) after the ovulation until the 9th weeks of gestation or placebo ( n = 33). Among patients treated with G‐ CSF , 29/35 (82.8%) have live birth and 16/33 (48.5%) of controls ( P = 0.006). Among 200 women with recurrent miscarriages and implantation failure treated with intralipids, the pregnancy rate was 52%, with pregnancy ongoing/live birth rate at 91%. The physiopathological rational for immunotolerance failure in this topic raise the need to demonstrate the efficacy of immunomodulatory drugs, define the patients subsets and develop treatment strategies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/aji.12493

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 174

Metadata

Authors
Mekinian, A., Cohen, J., Alijotas‐Reig, J., Carbillon, L., Nicaise‐Roland, P., Kayem, G., Daraï, E., Fain, O., & Bornes, M.
Venue
American Journal of Reproductive Immunology
Publisher
Wiley
Published
2016-02-05
Volume
76
Issue
1
Pages
8-28
ISSN
  • 0271-7352 (ISSN-L)
  • 1046-7408
  • 1600-0897
OpenAlex
W2255265887
Cited by
174
References
8
FWCI
5.72
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Unexplained Recurrent Miscarriage and Recurrent Implantation Failure: Is There a Place for Immunomodulation? https://app.cochat.ai/papers/10.1111/aji.12493
The paper
Mekinian, A., Cohen, J., Alijotas‐Reig, J., Carbillon, L., Nicaise‐Roland, P., Kayem, G., Daraï, E., Fain, O., & Bornes, M. (2016). Unexplained Recurrent Miscarriage and Recurrent Implantation Failure: Is There a Place for Immunomodulation? American Journal of Reproductive Immunology. https://doi.org/10.1111/aji.12493

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.